NGS-based RNA-sequencing Market: Is 2026 the Year...

أضاف وظيفة جديدة Health

2026-02-12 05:59:00 -

NGS-based RNA-sequencing Market: Is 2026 the Year "Transcriptome Profiling" Becomes a Standard Diagnostic for Every Cancer Patient?

In early 2026, the NGS-based RNA-sequencing Market is reaching a massive valuation of $5.93 billion, marking a shift from gene "mapping" to gene "activity" monitoring. This year, the industry is seeing the widespread adoption of Single-Cell RNA-seq (scRNA-seq), which allows scientists to see exactly which genes are "switched on" in every individual cell within a tumor. This innovation is a...

0 التعليقات 0 المشاركات 201 مشاهدة 0 معاينة